🔎 Trials Near Me

Почетна › Акутна миелоидна леукемија › Мисури › St. Louis

Клинички испитувања за Акутна миелоидна леукемија во St. Louis, MO

22 студии за Акутна миелоидна леукемија бараат учесници на локации во и околу St. Louis (во радиус од околу 30 милји). Отворете ја студијата за да видите кој може да учествува и како да го контактирате тимот.

Официјален текст на студијата (англиски)

Барате учесници за студија? Истакнете ја на врвот од оваа страница — $99 за 30 дена →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

Се регрутираФаза 2
  • Washington University School of Medicine, St Louis
  • Siteman Cancer Center-South County, St Louis
  • Missouri Baptist Medical Center, St Louis
  • и уште 3
Возраст 18 и постари · Сите полови · Ажурирано 5.10.2026 · NCT05564390

A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)

Се регрутираФаза 2/3
  • Washington University /ID# 280295, St Louis
Возраст 18 и постари · Сите полови · Ажурирано 2.10.2026 · NCT07581002

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
  • Mercy Infusion Center - Chippewa, St Louis
  • Mercy Hospital South, St Louis
  • Missouri Baptist Medical Center, St Louis
  • и уште 4
Возраст од 40 до 75 · Сите полови · Ажурирано 2.10.2026 · NCT05334069

Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

Се регрутираФаза 1
  • Washington University School of Medicine, St Louis
  • Siteman Cancer Center-South County, St Louis
  • Siteman Cancer Center at Christian Hospital, St Louis
  • и уште 1
Возраст 18 и постари · Сите полови · Ажурирано 1.10.2026 · NCT06484062

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

Се регрутираФаза 2
  • Washington University School of Medicine, St Louis
  • Siteman Cancer Center-South County, St Louis
  • Siteman Cancer Center at Christian Hospital, St Louis
  • и уште 2
Возраст од 18 до 59 · Сите полови · Ажурирано 28.9.2026 · NCT05554393

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

Се регрутираФаза 3
  • Washington University in St Louis, St Louis
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT06852222

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

Се регрутираФаза 2
  • Washington University School of Medicine, St Louis
  • Siteman Cancer Center-South County, St Louis
  • Siteman Cancer Center at Christian Hospital, St Louis
  • и уште 2
Возраст од 18 до 59 · Сите полови · Ажурирано 22.9.2026 · NCT05554406

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

Се регрутираФаза 2
  • Washington University School of Medicine, St Louis
  • Siteman Cancer Center-South County, St Louis
  • Siteman Cancer Center at Christian Hospital, St Louis
  • и уште 3
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT06317649

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

Се регрутираФаза 3
  • Washington University School of Medicine, St Louis
  • Mercy Hospital Saint Louis, St Louis
6 Months – 21 Years · Сите полови · Ажурирано 17.9.2026 · NCT04293562

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

Се регрутираФаза 1/2
  • Washington University in St. Louis School of Medicine, St Louis
30 Days · Сите полови · Ажурирано 16.9.2026 · NCT04065399

A Longitudinal Multi-Center Molecular Biomarker Discovery Registry for Patients With Hematologic Malignancies

Се регрутираНабљудувачка студија
  • Washington University in St. Louis, St Louis
Возраст 0 и постари · Сите полови · Ажурирано 2.9.2026 · NCT07154823

Bleximenib in Combination With Standard Induction and Consolidation Therapy Followed by Maintenance for Treatment of Patients With Acute Myeloid Leukemia (AML)

Се регрутираФаза 3
  • US-St Louis MO-WASHU, St Louis
Возраст 18 и постари · Сите полови · Ажурирано 1.9.2026 · NCT07223814

Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML

Се регрутираФаза 1
  • Washington University in St Louis, St Louis
Возраст 18 и постари · Сите полови · Ажурирано 25.8.2026 · NCT06533761

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

Се регрутираФаза 1/2
  • Cardinal Glennon Children's Medical Center, St Louis
  • Washington University School of Medicine, St Louis
  • Mercy Hospital Saint Louis, St Louis
До возраст 22 · Сите полови · Ажурирано 25.8.2026 · NCT04726241

Pilot Study of Memory-like Natural Killer (ML NK) Cells After TCRαβ T Cell Depleted Haploidentical Transplant in AML

Се регрутираФаза 1/2
  • Washington University School of Medicine, St Louis
Возраст 18 и постари · Сите полови · Ажурирано 24.8.2026 · NCT06158828

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

Се регрутираФаза 3
  • Washington University School of Medicine in St. Louis, St Louis
29 Days – 21 Years · Сите полови · Ажурирано 24.8.2026 · NCT05183035

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

Се регрутираФаза 1
  • Washington University School of Medicine, St Louis
Возраст 18 и постари · Сите полови · Ажурирано 20.8.2026 · NCT06001788

Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell Transplantation

Се регрутираФаза 2
  • Washington University, St Louis
Возраст 18 и постари · Сите полови · Ажурирано 11.8.2026 · NCT06529731

Motixafortide for MRD Sensitization in AML

Се регрутираФаза 2
  • Washington University School of Medicine, St Louis
Возраст 18 и постари · Сите полови · Ажурирано 24.7.2026 · NCT07392970

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

Се регрутираНабљудувачка студија
  • Cardinal Glennon Children's Medical Center, St Louis
  • Washington University St. Louis, St Louis
  • Washington University/St. Louis Children's Hospital, St Louis
Сите возрасти · Сите полови · Ажурирано 6.7.2026 · NCT01351545

A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias

Се регрутираФаза 1
  • Washington University in St. Louis, St Louis
Возраст 12 и постари · Сите полови · Ажурирано 16.3.2026 · NCT06994676

Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in AML and MDS

Се регрутираДобредојдени се здрави волонтери
  • Washington University School of Medicine, St Louis
Возраст 18 и постари · Сите полови · Ажурирано 16.10.2025 · NCT04986657

Испитувања за Акутна миелоидна леукемија во други градови

Други студии во St. Louis

Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.